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Human adenoviruses comprise an important group of etiologic agents that are responsible
for various diseases in adults and children, such as respiratory, ocular, gastroenteric, and uri-
nary infections. In immunocompromised and organ-transplanted individuals, these agents
can  cause generalized infections. Rapid diagnostic methods for detecting these infectious
agents are not widely available.
The aim of this work was to produce monoclonal and polyclonal anti-adenovirus antibod-
ies  to be used in a rapid diagnostic test for respiratory infections.
Adenovirus hexons were satisfactorily purified by ultracentrifugation and chromatog-
raphy. After virus purification, anti-hexon monoclonal antibodies were produced and
characterized, following classical methods. Antibodies were specific for adenoviruses 2, 3, 5,
and  41. The proposed immunochromatographic test was standardized using colloidal gold.
The  standardization of the rapid test was sufficient to detect adenovirus antigens (in
nasopharyngeal lavage samples) with sensitivity of 100% and specificity of 85% when com-
pared to direct immunofluorescence.
The immunochromatographic assay prototype was sufficiently sensitive to detect B (3),
C  (2 and 5), and F (41) adenovirus samples. Although based on preliminary data, the test
demonstrated the same performance as direct immunofluorescence, but with the advantage
of  being a point-of-care test. Further studies are still needed to confirm its effectiveness inclinical practice.
Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an© 2017 Sociedade open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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(feeder), mouse macrophages of the BALB/c strainb r a z j i n f e c t d i s .
ntroduction
uman adenoviruses (HAdVs) are important agents that cause
erious infections in children and immunocompromised
atients. HAdVs were first detected in military personnel with
cute febrile respiratory disease. Later, clinical manifestations
uch as gastroenteritis, cystitis, hepatitis, keratoconjunctivi-
is, meningoencephalitis, and myocarditis were also related
o these viruses.1–10
The epidemiological studies of adenovirus infections have
imitations due to the relatively high incidence of doubt-
ul and inconclusive results obtained in the tests currently
n use. Direct immunofluorescence (IFD) and Enzyme Linked
mmunonoSorbent Assay (ELISA) assays are techniques that
re not very sensitive for the diagnosis of adenovirus infec-
ions, compared to cell culture methods and molecular
iagnosis.3–5,10
Virus isolation in cell cultures is a sensitive method for
denovirus detection, but this method is costly and time-
onsuming, taking several days to perform the isolation. As
ome adenovirus serotypes are difficult to culture, in order to
aximize sensitivity the virus should culture on at least two
r three different cell lines.10 The turn-out of culture results
re immediately provided to the clinician, and are impractical
n studies with a large number of clinical samples.3,10
Molecular diagnosis by PCR (Polymerase Chain Reaction) is
 relatively quick and sensitive tool, enabling direct labora-
ory diagnosis in the clinical sample.10 Depending on the DNA
egion amplified by PCR, it is possible to distinguish between
pecies and serotypes.10 However, this technique still has a
igh cost and requires a specialized technical team to perform
t, and it is therefore not very accessible.3,9,10
In this study, the purified adenovirus antigen was used
n the production of monoclonal and polyclonal antibodies,
hich in turn were applied to a nitrocellulose membrane. The
apid test prototype consisted of anti-hexon polyclonal anti-
odies coupled to the glass fiber superimposed on high-flow
itrocellulose 180.
The combination of the 6D-1G monoclonal antibody on the
est line (capture) with gold-conjugated rabbit polyclonal anti-
odies (fiber glass/detection) provided better specificity and
ensitivity. When 6D-1G (concentration 1.2 mg/mL) was tested
ith sucrose (3%) and trehalose (2.5%), there was successful
etection of adenoviruses 2, 3, 5, and 41.
In the configuration of the proposed adenovirus detection
est the monoclonal antibody was bound to a nitrocellu-
ose membrane and the polyclonal antibody to a glass fiber
embrane, and this proved to be a promising format in
he standardization of an immunochromatographic assay for
etecting all adenovirus serotypes.29
aterial  and  methods
roduction  of  adenovirus  hexons/purification  stocks,
lectron  microscopy  and  virus  concentrationroduction of adenovirus stocks and purification, electron
icroscopy, and virus concentration were performed as7;2 1(5):500–506 501
previously described.11–19 The protein content was measured
by bicinchoninic acid method.20
Production  of  polyclonal  antibodies
Immunization  of  BALB/c  mice
Virus antigen was purified using cesium chloride gradient
centrifugation and dialysis against 10 mM HEPES buffer, pH
7.4, 10% glycerol and 1 mM EDTA. Nine male BALB/c mice of
approximately six weeks were immunized intraperitoneally
(i.p.) as follows20: injection of 50 g adenovirus hexon pro-
tein (pure antigen) diluted in Freund’s adjuvant. The booster
dose was performed with i.p. injection of approximately 50 g
antigen in Freund’s incomplete adjuvant. The third dose was
performed i.p. injection of approximately 50 g antigen in Fre-
und’s incomplete adjuvant. The fourth dose was administered
with injection with 50 g antigen in Freund’s incomplete adju-
vant. Finally, spleen cells were used for the fusion.
Production/purification of polyclonal antibodies in rabbit
was performed as previously described.20–22
Indirect  ELISA  of  polyclonal  antibodies  from  BALB/c  mice
Selection of positive mice, i.e., those that produced adeno-
virus antigen-specific antibodies, was based on the result
of indirect ELISA test. The plate was coated with purified
“adenovirus hexon” diluted in 0.05 M carbonate/bicarbonate
buffer, pH 9.6 (50 L/well), at a concentration of approximately
10 g/well. The plate was incubated overnight at 4 ◦C and
subsequently washed once with 0.05% PBST, and blocking
solution (1% tryptone, 1% BSA, 3% sucrose (150 L/well)) in
PBS for 1 h at 37 ◦C was then added. The plate was washed
once with 0.05% PBST. Next, 50 L of sera were added to the
ELISA plate, which was then incubated at 37 ◦C for 1 h. The
negative control was PBS. The plate was  washed 3 times
with 0.05% PBST and then incubated with secondary anti-
body, horseradish peroxidase-conjugated goat anti-mouse IgG
(H+L) (Immunopure Pierce), diluted 1/10,000 in 0.05% PBST.
Peroxidase activity was revealed by the addition of ELISA sub-
strate TMB BD OptEIA. The reaction was stopped by adding
50 L/well of 3 N H2SO4 and the plate read on a TP Reader
Thermo Plate at a wavelength of 450 nm.20
Monoclonal  antibodies  production
Hybridoma  technology
Fusion was performed according to the protocol proposed by
Dr. Leticia Barboza’s group (Bacteriologia – Instituto Butantan).
Myeloma  cells from the Sp2/0-Ag14 line (ATCC CRL 1581-
Köhler and Milstein, 1976) were purchased from the Rio de
Janeiro Cell Bank (BCRJ). Cells were previously thawed, grown
in pre-fusion medium (RPMI 1640 medium (Invitrogen) plus
10% NCTC (Invitrogen) and 10% FBS) and kept in an incubator
at 37 ◦C in 5% CO2.
For the preparation of hybridoma conditioned mediumwere obtained by the intraperitoneal lavage procedure.
Macrophages were obtained by introducing 5 mL  of RPMI
1640 medium (4 ◦C) into the peritoneum. The medium was
i s . 2 0502  b r a z j i n f e c t d 
withdrawn with the macrophages and then centrifuged at
1200 rpm for 5 min. Finally, the cells were resuspended in RPMI
1640 medium with 10% NCTC and 10% FBS and incubated at
37 ◦C in 5% CO2.
Initially, two 25-cm2 and three 75-cm2 flasks of SP20 cells
were used in the assay. The cells were then counted in a
Neubauer chamber and placed in a 5% CO2 incubator at
37 ◦C, in approximately 5 mL  of pure DMEM.  The BALB/c mice
received the fourth booster dose of 50 g of purified “adeno-
virus” diluted in PBS three days prior to the fusion assay. The
immunized animals were sacrificed and the spleen and lymph
nodes removed. The spleen and lymph nodes were placed on
a screen on top of a beaker and DMEM was injected with a
needle and syringe (they swelled and burst easily and the
cells fell through the screen). The tissue was macerated on
the screen with the plunger of a glass syringe. The macer-
ates were placed in a Falcon tube and centrifuged at 1200 rpm
for 5 min. The supernatant was discarded and the splenocytes
and lymph node cells were resuspended in 5 mL  of medium.
The cells were then counted in a Neubauer chamber. SP2 cells
and splenocytes (in 1:2 ratio) were mixed in a Falcon tube.
Next, 10 mL  of pure DMEM were added and the tube was cen-
trifuged at 1200 rpm for 5 min. The supernatant was discarded
with the aid of a Pasteur pipette and the pellet was gently
broken with 0.5 mL  of pure DMEM.  Subsequently, 1 mL  of PEG
was added with 50 L of DMSO for 1 min, dropwise with slow
stirring, in a beaker with water at 37 ◦C, after which time the
cells were allowed to remain another minute in the beaker.
Subsequently, 2 mL  of pure DMEM were added dropwise with
gentle shaking; an additional 20 mL  of pure DMEM were then
added, and the cells were allowed to stand for 4 min  in water
at 37 ◦C. Thereafter, the tube with the cells was centrifuged at
1200 rpm for 5 min  at room temperature. For lymph node cells,
the pellet was resuspended in 10 mL  of complete medium:
DMEM + 3% HAT + 15% FBS and plated (100 L) in a 96-well
plate. For splenocytes, the pellet was resuspended in 30 mL
of complete medium: DMEM + 3% HAT + 15% FBS and plated
(100 L) in three 96-well plates. Finally, the cells were incu-
bated at 37 ◦C, 10% CO2. The medium was changed every three
days. After one week, 3% HAT was substituted with 2% HAT for
another three weeks.21
Indirect  ELISA  of  hybridoma  supernatant
Selection of positive hybridomas, i.e., those that produced ade-
novirus antigen-specific antibodies was performed by indirect
ELISA. Prior to this, standardization of this ELISA test was per-
formed using various concentrations of purified adenovirus
antigen, HEK cell antigens (negative control), and commercial
anti-adenovirus monoclonal antibody (positive control). This
ELISA with cross-titration allowed a cut-off to be established
so that truly positive hybridomas could be identified.
The plate was sensitized with purified adenovirus anti-
gen diluted in 0.05 M carbonate/bicarbonate buffer, pH 9.6
(50 L/well), at a concentration of approximately 0.5 g/well.
In addition, all hybridoma supernatants were tested against
HEK cell antigens (negative control) at a concentration of
0.0025 ng/well. The plate was then incubated overnight at
4 ◦C. Subsequently, it was washed once with 0.05% PBST and
then blocking solution (1% tryptone, 1% BSA, 3% sucrose 1 7;2  1(5):500–506
(150 L/well)) diluted in PBS for 1 h at 37 ◦C was added. Finally,
it was washed once with 0.05% PBST, and then, 100 L of
the hybridoma culture supernatant were incubated in the
ELISA plate at 37 ◦C for 1 h. Non-immunized mouse serum
was used as the negative control. Commercial anti-adenovirus
monoclonal antibody (Merck/positive control) was incubated
at a 1/3000 dilution. The plate was washed three times with
0.05% PBST and then incubated with goat anti-mouse IgG
secondary antibody (H+L) conjugated to horseradish perox-
idase (Immunopure Pierce) diluted 1/10,000 in PBS. Finally,
peroxidase activity was revealed by the addition of ELISA sub-
strate TMB BD OptEIA. The reaction was stopped by adding
50 L/well of 3 N H2SO4 and the plate subsequently read in a
spectrophotometer (TP Reader Thermo Plate) at 450 nm.21
Limiting  dilution  of  hybridomas
Hybridomas that had optical density close to or above the
estimated cut-off (OD = 0.548) – for purified adenovirus anti-
gen – were subjected to limiting dilution. Hybridomas were
detached from the flask and placed in a Falcon tube. The cells
were then counted in a Neubauer chamber. The cell count of
a 25-cm2 flask was around 3 × 105 cells/mL. From this calcu-
lation, a sequential dilution in other Falcon tubes (with 10 mL
of culture medium) was done until approximately 50 cells in
10 mL of medium were finally obtained. At the end, approx-
imately 100 L were incubated in a 96-well cell culture plate
and kept in an incubator at 37 ◦C and 5% CO2.21
Monoclonal  antibodies  characterization
Indirect  ELISA  of  purified  monoclonal  antibodies
The plate was sensitized with adenovirus (serotypes 2, 3, 5,
and 41) diluted with 0.05 M carbonate/bicarbonate buffer, pH
9.6 (50 L/well), at a concentration of approximately 0.5 g/mL.
In addition, all hybridoma supernatants were tested against
parainfluenza virus (negative control) respiratory tract cell
antigens at the same concentration, with overnight incubation
at 4 ◦C. Subsequently, the plate was washed once with 0.05%
PBST and then incubated with blocking solution (1% tryptone,
1% BSA, 3% sucrose) in PBS (150 L/well) for 2 h at 37 ◦C. Wells
were washed once with 0.05% PBST and then 100 L of puri-
fied monoclonal antibodies (5 g/mL) were added, followed by
incubation at 37 ◦C for 1 h. The plate was incubated with anti-
adenovirus monoclonal antibody (positive control) at 1/3000
dilution and washed six times with 0.05% PBST, and the
secondary antibody, horseradish peroxidase-conjugated goat
anti-mouse IgG (H+L) (Immunopure Pierce), diluted 1/10,000
in PBS, was added, followed by incubation for 40 min  at 37 ◦C.
The reaction was stopped by adding 50 L/well of 3 N H2SO4
and TMB BD OptEIA was added as substrate. The plate was
read on a plate spectrophotometer (TP Reader Thermo Plate)
at 450 nm.21
ELISA for isotype was performed as previously described.21
Protocols  for  immunochromatographic  testConjugation  of  colloidal  gold  with  antibody
The antibody(s) were resuspended (at a final concentration of
1 mg/mL) in 0.2 M NaCl–borate buffer pH 9.0, and then dialyzed
b r a z j i n f e c t d i s . 2 0 1 7;2 1(5):500–506 503
Lateral flow assay architecture
Analyte
Antibodies conjugated to
gold nanoparticles
Test line
 (Antibody)
Capillary flow
Control line
(e.g. anti-lgG antibody)
Sample
pad
Conjugate
pad Membrane Wicking pad
Test line
(Positive)
Control line
(Valid test)
Fig. 1 – Prototype of immunochromatographic test for detection of adenovirus. Test line (positive) and control line
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gainst 2 mM borate–NaCl buffer, pH 9.0 for 2 h. The amount
f antibody required to stabilize gold was determined: 100 L
f colloidal gold (20 nm,  1 OD or 0.01%, BBI) was added in
liquots containing 10 L of dilutions of dialyzed monoclonal
ntibody (in 2 mM borate). After 10 min, 11 L of 10% NaCl was
dded to each tube. The amount of antibody sufficient to sta-
ilize the gold was the dilution in which the solution did not
hange color, i.e., insufficient amount of antibody changes the
oloration of the solution from red to blue. Considering a dia-
yzed solution of antibodies at the approximate concentration
f 1 mg/mL, the volumes of 1–4 L were tested. Subsequently,
he pH of the gold to be conjugated to pH 9.0 was adjusted
ith 0.1 M K2O3 solution.
The colloidal gold was added to the stirring antibody,
llowed to react for 30 min  at room temperature (10 mL  of gold
olloidal in the amount of antibody determined in step 3). In
rder to stabilize the reaction, a 10% BSA solution (10% BSA in
.01 M borate buffer, pH 9.0) was mixed in sufficient volume
o reach a final concentration of 1% and incubated for 30 min.
he solution was centrifuged at 15,000 × g for 20 min  at 4 ◦C
nd the supernatant discarded. The pellet was resuspended
n 2 mL  of a 2% BSA in 0.01 M borate buffer and centrifuged
t 12,000 × g for 20 min  at 4 ◦C. Finally, the pellet was resus-
ended in 1 mL  of buffer (3% BSA, 3% sucrose, 0.01 M sodium
orate and 0.05% sodium azide) and stored at 4 ◦C.23
mmunochromatographic  assay
ach paper type was treated separately before assembling the
ape, as shown below: the sample pad(s) were immersed in
uffer (20 mM sodium borate buffer, 0.1% Triton X-100 and
.1% sodium azide, pH 8.5) and stored in a vacuum chamberat room temperature for 2 h or held at 56 ◦C for 2 h. Conjugate
pad(s) (solid phases with conjugate) were soaked with 20 L of
the pAb-gold solution. The fibers were then kept in an oven
at 37 ◦C for 2 h. Nitrocellulose membranes (HiFlow Plus nitro-
cellulose 180 – Merck) were incubated with 0.1 M Tris–HCl, pH
7.5, with 0.4% glycerol for 15 min  on a shaker. After immersion,
the membranes were washed 1× with 10 mM Na2HPO4 wash
buffer pH 7.5 and then placed in the oven at 37 ◦C for 18–20 h for
drying. Subsequently, 1.5 L 6D-1G monoclonal antibody (con-
centration 1.2 mg/mL) diluted in 0.01 M PBS pH 7.2 (test line)
were applied. Then, 1.2 mg/mL  rabbit anti-IgG was applied
after 0.5 cm of the test line (control line). The membranes were
then kept in a vacuum chamber for 2 h. The strips were set for
drying at room temperature overnight or in the vacuum cham-
ber for 2 h. The absorbing pad(s) (solid absorption phases) need
no treatment. The diluent (0.01 PBS containing 0.1% Triton X-
100 and 0.5% BSA) improved the migration rate of the sample
(1:1 diluent/sample). For assembling the tests, the pretreated
papers were overlapped according to Fig. 1.23
Ethics  in  Research  Committee
The study was approved by the Ethics in Research Committee
of the Universidade Federal de São Paulo, No. 0126/2011.
Results  and  discussionThe precise diagnosis of a case of adenovirus infection is
important in order to avoid the spread of the disease, espe-
cially in closed institutions, such as nurseries, hospitals,
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Fig. 2 – Indirect ELISA of purified monoclonal antibodies (individual and combined reactions against culture adenovirus
prototypes 41, 3, 2, and 5).
clinics, schools and places with crowds of people1–5,8–10,22,24–26
as well as to avoid unnecessary use of medications.
Ideally, a diagnostic method for any infectious disease
should be fast and inexpensive in the performance/outcome,
have a good sensitivity/specificity ratio, and not require per-
sonnel with specialized training to perform it.9 Udeh et al.
(2008) estimated that approximately $400 million per year of
health resources could be saved with an accurate diagnosis
of adenoviruses associated with conjunctivitis in the United
States alone. In addition, 1.1 million cases of inappropriate
use of antibiotics would be avoided.9,10
Viral isolation through cell culture remains the gold
standard in the diagnosis of adenovirus because the isolation
of the infectious agent is definitive. However, it is a time con-
suming technique, requires specialized personnel to perform,
and has a high cost. The PCR technique is sensitive enough
for detection, but it has a very high cost and requires highly
qualified personnel for the diagnostic procedure.9,10
In the case of immunocompromised patients, rapid direct
test (viral protein screening) has an advantage over indirect
ELISA (serology) test since patients under these conditions do
not have levels of antibodies high enough to be detected.5,10
Levent et al. (2009) evaluated an immunochromatographic
assay for adenovirus (SAS adeno-test) and observed a sensi-
tivity of 55% and specificity of 98.9% for samples from children
with influenza-like illness.4 Romero-Gomez et al. (2014) ana-
lyzed the Adeno respiratory card letitest (Leti diagnostics
Barcelona, Spain) in 224 samples of children under 15 whoattended an emergency room. When compared to PCR, the
rapid test showed sensitivity of 78% and specificity of 73%. In
addition, the researchers speculated that the low specificity
of the test indicated that it could be used in clinical decision
making during the period of greatest adenovirus replicative
activity.27
The antigen-capture immunochromatographic assay uses
a strip consisting of three types of membranes (cellulose fiber,
glass fiber, and nitrocellulose), mounted on a plastic support.
In the strip, the cellulose fiber is located at the anterior and
posterior ends, being interspersed by glass fiber and nitro-
cellulose. The test uses two antibodies that bind to different
epitopes present in the molecule to be detected (analyte)
(Fig. 1). One of the antibodies, labeled with a signal genera-
tor such as latex beads or colloidal gold, is called the detection
antibody, while the second antibody is called the capture anti-
body. The detection antibody is placed in a dehydrated state
on the glass fiber membrane, which will allow its instant dis-
solution upon contact with the aqueous medium containing
the analyte. Under these conditions, the analyte binds to the
antibody forming a complex, which migrates by capillarity on
the strip until binding with the capture antibody, which was
previously fixed on the nitrocellulose membrane. The cellu-
lose fiber, located at the ends, provides the continuous flow
of the complex. The color signal, generated by binding the
complex to the capture antibody, is visualized as a line after
10–20 min  and can be analyzed qualitatively and/or quantita-
tively. For control of the reaction, a specific antibody to the
b r a z j i n f e c t d i s . 2 0 1 
+
T C
_
Fig. 3 – Prototype of immunochromatographic test. C:
control line. T: test line. Detection of cultured adenovirus
(
d
o
b
t
d
t
t
d
t
c
d
H
r
h
c
c
o
a
f
b
i
1
d
T
t
m
P
m
1
t
a
s
s
rprototypes) 2, 3, 5, and 41 was successful.
etection antibody is placed on the nitrocellulose membrane
n the same strip. The reaction is considered positive when
oth test and control lines show the characteristic color after
he reaction time.2,4,6,8,25–27
In our study, the processes of adenovirus antigen pro-
uction and chromatography resulted in good purification of
he material.13,14,18,20,22,28 Elution fractions of the hexon pro-
ein were found at the same concentrations as previously
escribed.13–17,20,22 After immunoblotting, it was confirmed
hat the polyclonal serum of BALB/c mice contained spe-
ific antibodies against adenovirus hexon as previously
escribed.15,20,22 The hexon immunization protocol used by
ongling et al. (2009) was satisfactory, since excellent humoral
esponse was obtained in BALB/c mice and rabbits. Three
ybridomas (6D-1G, 6D-4E, and 6D-7C) were maintained in
ulture and the antibodies produced were able to recognize
ultured adenovirus (prototypes) 2, 3, 5, and 41 (Fig. 2). The cut-
ff value to determine the reactivity of different monoclonal
ntibodies was established by testing seronegative samples
or adenovirus antibodies and multiplying the medium value
y 2.1 (95% upper limit of variability). All hybridomas showed
sotype IgG1 (data not shown).
In this study, when 6D-1G antibody (concentration
.2 mg/mL  with sucrose 3% and trehalose 2.5%) was tested,
etection of adenovirus 2, 3, 5, and 41 was successful (Fig. 3).
he fiberglass containing polyclonal antibodies (concentra-
ion 1.2 mg/mL) was superimposed on the nitrocellulose
embrane (HiFlow Plus nitrocellulose 180). The diluent (0.01 M
BS containing 0.1% Triton X-100 and 0.5% BSA) improved the
igration rate of the sample. This format was promising since
00% sensitivity and 85% specificity was achieved in the detec-
ion of adenovirus in samples of pediatric patients already
nalyzed by IFD (Table 1). New assays with a larger number of
amples are still needed to confirm this performance. Negative
amples can be targeted for cell culture testing and PCR.
Table 1 – Comparison of a rapid test with direct
immunofluorescence for detection of adenovirus directly
in clinical specimens obtained from pediatric patients.
Rapid test IFD
Positive Negative Total
Positive 48 3 51
Negative 0 14 14
Total 48 17 657;2 1(5):500–506 505
Conclusions
This first work aimed to describe in more  detail the prepara-
tion of a prototype and did not intend to evaluate the test in
its final format, although the preliminary results were quite
encouraging. Once standardized in greater detail, this rapid
assay prototype will have applicability in the accurate and
rapid diagnosis of respiratory infections at the emergency
room. Its use will bring benefits when there is suspicion of
outbreaks, allowing the physician to prescribe immediate and
appropriate treatment for the disease.
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